YAP1 and neoplasm: The LATS-K697R construct, part of the Hippo tumor suppressor pathway, abolishes the LATS kinase function by disrupting the ATP-binding site (lysine-to-arginine mutation), preventing it from phosphorylating and inactivating YAP/TAZ.